Hua Medicine (Shanghai) Ltd.
HUMDF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $255,892 | $76,610 | $17,599 | $0 |
| % Growth | 234% | 335.3% | – | – |
| Cost of Goods Sold | $131,168 | $39,236 | $9,910 | $0 |
| Gross Profit | $124,724 | $37,374 | $7,689 | $0 |
| % Margin | 48.7% | 48.8% | 43.7% | – |
| R&D Expenses | $215,092 | $171,537 | $129,528 | $186,835 |
| G&A Expenses | $116,755 | $124,148 | $129,931 | $134,835 |
| SG&A Expenses | $269,937 | $203,903 | $145,279 | $134,835 |
| Sales & Mktg Exp. | $153,182 | $79,755 | $15,348 | $0 |
| Other Operating Expenses | -$7,661 | -$48,974 | $0 | $0 |
| Operating Expenses | $477,368 | $326,466 | $274,807 | $321,670 |
| Operating Income | -$352,644 | -$289,092 | -$267,118 | -$320,517 |
| % Margin | -137.8% | -377.4% | -1,517.8% | – |
| Other Income/Exp. Net | $102,500 | $77,858 | $63,611 | -$4,064 |
| Pre-Tax Income | -$250,144 | -$211,234 | -$203,507 | -$325,734 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$250,144 | -$211,234 | -$203,766 | -$330,951 |
| % Margin | -97.8% | -275.7% | -1,157.8% | – |
| EPS | -0.25 | -0.22 | -0.21 | -0.34 |
| % Growth | -13.6% | -4.8% | 38.2% | – |
| EPS Diluted | -0.25 | -0.22 | -0.21 | -0.34 |
| Weighted Avg Shares Out | 981,392 | 977,055 | 966,730 | 957,489 |
| Weighted Avg Shares Out Dil | 981,392 | 977,055 | 966,730 | 957,489 |
| Supplemental Information | – | – | – | – |
| Interest Income | $13,438 | $16,512 | $4,240 | $5,036 |
| Interest Expense | $8,609 | $7,907 | $3,667 | $3,950 |
| Depreciation & Amortization | $34,583 | $36,238 | $31,777 | $11,984 |
| EBITDA | -$206,952 | -$167,089 | -$168,063 | -$309,686 |
| % Margin | -80.9% | -218.1% | -955% | – |